IDH1/2 mutations have also been found in several types of cancers, covering enchondroma, chondrosarcoma, angioimmunoblastic T cell lymphoma (AITL), intrahepatic cholangiocarcinoma (ICC), and acute myeloid leukemia (AML) [27]. This evidence concerns the gene IDH1 and angioimmunoblastic T-cell lymphoma.